Zimmer Biomet (ZBH) Stock Analysis: AI Score & Alternative Data
ZBH alt-data: web traffic climbing, business outlook lagging
Is Zimmer Biomet a buy right now? The alternative data says hold. This ZBH stock analysis is built on the 25+ alternative data signals AltIndex tracks on Zimmer Biomet every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 50/100: a Hold. The stock trades at $94.61 with a $19B market cap.
The bullish side of the 90-day ledger: web traffic up 17.5% to 380K monthly visits, and job postings up 6.0% to 547 open roles. The drag: just 46% of employees report a positive business outlook. That tension is what keeps the score mid-range.
ZBH’s broader alt-data profile also covers headcount (19K employees, according to LinkedIn), quarterly revenue ($2.2B), Facebook followers (37K), and sentiment (100/100). Every signal links to its own page with full history, the ZBH technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on ZBH is just below.
Zimmer Biomet AI Stock Analysis
Zimmer Biomet is a prominent player in the medical technology sector, specializing in the design, manufacture, and marketing of orthopedic reconstructive products, including knee, hip, and shoulder replacements.
Analysis generated September 2, 2026.
Recent Zimmer Biomet Stock Alerts
|
Zimmer Biomet | September 8 Price is down by -6.3% in the last 24h. |
|
Zimmer Biomet | August 13 Ro Khanna (member of U.S. congress) is selling shares |
|
Zimmer Biomet | August 3 Job postings are down by 21.7% in the last couple of days. |
|
Zimmer Biomet | August 2 Job postings are down by 19.7% in the last couple of days. |
Zimmer Biomet Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 380K | 17.5% | |
| Job Posts | 547 | 6.0% | |
| LinkedIn Employees | 19K | 2.8% | |
| Employee Recommend | 61 | 1.7% | |
| Business Outlook | 46 | 2.2% | |
| Sentiment | 100 | 0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 6 | 40.0% | |
| Stocktwits Mentions | 2 | 0% | |
| News Mentions | 1 | N/A | |
| Stocktwits Subscribers | 1K | 0% | |
| 4chan Mentions | 0 | N/A | |
| X Followers | 12K | 0% | |
| Youtube Subscribers | 5K | 2.1% | |
| Facebook Followers | 37K | 0% | |
| Facebook Engagement | 31 | 121.4% |
About Zimmer Biomet (ZBH)
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
| Price | $94.61 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $19B |
| Year Range | $79 – $103 |
| Dividend Yield | 0% |
| PE Ratio | 23.8 |
| Analyst Rating | 38% buy |
| Industry | Medical Devices |
Latest Zimmer Biomet News
View more → |
Zimmer Biomet Announces Americas Leadership Promotions to Accelerate Commercial TransformationSeptember 8 - PRNewswire |
 |
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2026August 28 - PRNewswire |
 |
Are Wall Street Analysts Bullish on Zimmer Biomet Stock?August 14 - Biztoc.com |
Zimmer Biomet Q2 Earnings Call HighlightsAugust 9 - MarketBeat |
|
Zimmer Biomet reports 4.8% YoY revenue uptick in Q2; raises 2026 outlookAugust 5 - Medical Device Network |
See Zimmer Biomet’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for ZBH, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREEZimmer Biomet Earnings & Financial Performance
View all earnings →Zimmer Biomet Insider Trading Activity
View all →| Yi Sang filed to sell 27,251 shares at $0.0. May 29 '26 |
| Yi Sang filed to sell 28,051 shares at $0.0. May 29 '26 |
| Winkler Lori filed to sell 10,224 shares at $0.0. Mar 12 '26 |
| Yi Sang filed to sell 17,670 shares at $0.0. Feb 12 '26 |
| Yi Sang filed to sell 18,584 shares at $0.0. Sep 11 '25 |
Zimmer Biomet Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Ro Khanna |
Aug 12, 26 | Sell | $8K+ |
| Ro Khanna |
Aug 12, 26 | Sell | $8K+ |
| Ro Khanna |
Aug 8, 25 | Buy | $8K+ |
| Ro Khanna |
Jul 10, 25 | Buy | $8K+ |
| Rob Bresnahan |
Jun 2, 25 | Sell | $8K+ |
Stocks Similar to Zimmer Biomet
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
MedpaceMEDP |
$586.30 0.8% | $17B | 54 |
 |
CooperCompaniesCOO |
$63.48 6.2% | $14B | 42 |
 |
PenumbraPEN |
$319.57 0.1% | $13B | 55 |
 |
Globus MedicalGMED |
$74.52 0.7% | $11B | 54 |
 |
GlaukosGKOS |
$179.79 2.8% | $10B | 50 |
Explore Zimmer Biomet Data
Frequently Asked Questions: Zimmer Biomet (ZBH)
Zimmer Biomet has an AltIndex AI Score of 50/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
50/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Zimmer Biomet (ZBH) stock is $94.61 with a market cap of $19B.
As of today, Zimmer Biomet’s PE (Price to Earnings) ratio is 23.8.
View the latest Zimmer Biomet insider transactions to see recent buying and selling activity by company executives and directors.
Check the Zimmer Biomet congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The ZBH stock price chart above shows Zimmer Biomet’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Zimmer Biomet technical analysis for RSI, moving averages, and more.
See the stocks similar to Zimmer Biomet section on this page for companies in the same industry ranked by market cap and AI Score.
